Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Viviana Galimberti

Showing results (1-10 of 186) with videos related to

Pageof 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2005
International Breast Cancer Study Group Trial of sentinel node biopsyViviana Galimberti
The Lancet. Oncology|June 4, 2013
Axillary versus sentinel-lymph-node dissection for micrometastatic breast cancer--authors' replyViviana Galimberti, Bernard F Cole
Breast (Edinburgh, Scotland)|May 7, 2013
DCIS and LCIS are confusing and outdated terms. They should be abandoned in favor of ductal intraepithelial neoplasia (DIN) and lobular intraepithelial neoplasia (LIN)Viviana Galimberti, Simonetta Monti, Mauro Giuseppe Mastropasqua
Breast (Edinburgh, Scotland)|June 11, 2016
Overexploring and overtreating the axillaViviana Galimberti, Giovanni Corso, Simonetta Monti, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|March 30, 2018
Prognosis and outcome in CDH1-mutant lobular breast cancerGiovanni Corso, Paolo Veronesi, Virgilio Sacchini, et al.
Breast Cancer Research and Treatment|November 19, 2018
Clinical implication of E-cadherin deficiency in lobular breast cancerGiovanni Corso, Gabriella Pravettoni, Viviana Galimberti, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 17, 2017
Axillary blue sentinel lymph node: an unusual tattoo?Giovanni Corso, Denise Mattar Fanianos, Viviana Galimberti, et al.
Familial Cancer|January 14, 2016
CDH1 germline mutations and hereditary lobular breast cancerGiovanni Corso, Mattia Intra, Chiara Trentin, et al.
Ecancermedicalscience|July 11, 2017
The Veronesi quadrantectomy: an historical overviewGiovanni Corso, Paolo Veronesi, Virgilio Sacchini, et al.
Biomarkers in Medicine|July 13, 2017
PIK3CA oncogenic mutations in neoadjuvant treatments for breast cancerGiovanni Corso, Paolo Veronesi, Mattia Intra, et al.
Pageof 19

Showing results (1-10 of 186) with videos related to

Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2005
International Breast Cancer Study Group Trial of sentinel node biopsyViviana Galimberti
The Lancet. Oncology|June 4, 2013
Axillary versus sentinel-lymph-node dissection for micrometastatic breast cancer--authors' replyViviana Galimberti, Bernard F Cole
Breast (Edinburgh, Scotland)|May 7, 2013
DCIS and LCIS are confusing and outdated terms. They should be abandoned in favor of ductal intraepithelial neoplasia (DIN) and lobular intraepithelial neoplasia (LIN)Viviana Galimberti, Simonetta Monti, Mauro Giuseppe Mastropasqua
Breast (Edinburgh, Scotland)|June 11, 2016
Overexploring and overtreating the axillaViviana Galimberti, Giovanni Corso, Simonetta Monti, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|March 30, 2018
Prognosis and outcome in CDH1-mutant lobular breast cancerGiovanni Corso, Paolo Veronesi, Virgilio Sacchini, et al.
Breast Cancer Research and Treatment|November 19, 2018
Clinical implication of E-cadherin deficiency in lobular breast cancerGiovanni Corso, Gabriella Pravettoni, Viviana Galimberti, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 17, 2017
Axillary blue sentinel lymph node: an unusual tattoo?Giovanni Corso, Denise Mattar Fanianos, Viviana Galimberti, et al.
Familial Cancer|January 14, 2016
CDH1 germline mutations and hereditary lobular breast cancerGiovanni Corso, Mattia Intra, Chiara Trentin, et al.
Ecancermedicalscience|July 11, 2017
The Veronesi quadrantectomy: an historical overviewGiovanni Corso, Paolo Veronesi, Virgilio Sacchini, et al.
Biomarkers in Medicine|July 13, 2017
PIK3CA oncogenic mutations in neoadjuvant treatments for breast cancerGiovanni Corso, Paolo Veronesi, Mattia Intra, et al.
Pageof 19